Tag Archives: Diabetes Moonshot

How GO-Pen’s “Insulin Pen for All” Is Making High-Quality T1D Care Globally Accessible



Our StartUp Health NOW guest this week is Ole Kjerkegaard Nielsen, PhD, CEO & Co-founder of GO-Pen, a company in our Type 1 Diabetes Moonshot community.

As you’ll hear, Nielsen and his team based in Denmark have built a new kind of insulin pen, one that is affordable and accessible to all while also adhering to the absolute highest standards of quality. This more accessible insulin pen could change millions of people’s lives.

We’ll also get a glimpse into the uniquely challenging startup journey of developing a physical medical device. Nielsen and his team have been winning awards and grants on a regular basis, but the road is still steep. Whether it’s negotiating with a manufacturer across the globe or getting FDA approval, bringing a medical device to market as a startup with limited funds is a challenge that could intimidate even the most market-tested CEOs. Nielsen pulls back the curtain and lets us see that challenge from the inside and shows us where GO-Pen is going next.

Enjoy!


FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


Former Dexcom Exec Claudia Graham Joins StartUp Health’s New T1D Moonshot Impact Board



“The more you know, the better you’ll do living with diabetes,” says Claudia Graham. “There’s nothing more important in diabetes than empowering patients.”

If you follow StartUp Health at all, you have seen headlines about our new Type 1 Diabetes Moonshot. To recap, we’ve launched an initiative designed to speed up innovation around Type 1 diabetes by bringing together a cross-disciplinary team of investors, entrepreneurs, philanthropists, researchers, and other industry experts. At the heart of the effort is an Impact Board – basically our T1D dream team – which brings together the top minds in the field for collaborative working sessions. We wanted to take some time on this podcast to introduce you to some of the inspiring folks on this Impact Board and invite you to get involved in the effort.

On this episode you’ll meet Claudia Graham, former executive at Dexcom, the company that revolutionized the continuous glucose monitor. She served as VP of Marketing and SVP of Global Access. Now she’s putting her decades of experience at Dexcom – and as someone living with Type 1 diabetes – to work as an advisor and investor. We caught up with Claudia over zoom at her home in Idaho to learn about the opportunities and challenges she sees in the Type 1 Diabetes Moonshot, how StartUp Health helps get away from institutional thinking to break down barriers and empower patients, and how she thinks about leaving a legacy for the next generation.


Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

 


David Weingard Breaks Down the Mission and Vision of StartUp Health’s New T1D Moonshot



This week’s episode is a conversation with a very special guest, David Weingard. For years StartUp Health backed his work as a founder as he built up a startup called Cecelia Health that provides a combination of high-tech and high-touch care for people with diabetes. Now David is leading a new initiative here at StartUp Health, the Type 1 Diabetes Moonshot. As the Chief Impact Officer, David has brought together an all-star team of T1D advocates to further this moonshot by onboarding investors, entrepreneurs, and researchers who are building the future of health. Hear how the Type 1 Diabetes Moonshot Impact Board is breaking down silos and speeding up innovation — and how you can join the effort.


 

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.